Strahlman currently works at Altria Group, Inc., as Independent Director from 2020, Losonoco Ltd., as Director from 2009, and Eyenovia, Inc., as Independent Director from 2022. Dr. Strahlman also ...

This pharma giant was expected to deliver for investors after its split with Haleon, but the GSK share price has underperformed the market. The post What’s going on with the GSK share price now?

GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 ...

Q1 2025 Earnings Call Transcript April 30, 2025 GSK plc beats earnings expectations. Reported EPS is $1.13, expectations were ...

Dr. Kate Knobil joins the biotech as it looks to combat a viral infection that can be dangerous to patients with the lung ...

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as ...

The Cervarix market report offers a comprehensive analysis of market size, growth potential, and segmentation, highlighting trends across major regions. Key drivers include rising HPV awareness, ...

European stocks closed higher on Wednesday, as investors pored through another slew of earnings and reacted to ...

GSK plc (GSK) on Wednesday reported ...

GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.

The Elton John AIDS Foundation is delighted to announce the appointment of three new members to its Board of Directors - ...